Role of 11C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy

European Journal of Radiology

Volumn 81, Issue 8, 2012, Pages

  Fuccio, Chiara ^a   Castellucci, Paolo ^a   Schiavina, Riccardo ^a   Guidalotti, Pier Luigi ^a   Gavaruzzi, Gilberto ^a   Montini, Gian Carlo ^a   Nanni, Cristina ^a   Marzola, Maria Cristina ^b   Rubello, Domenico ^b   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b 'Santa Maria della Misericordia' Hospital   (Italy)

Author keywords

11C choline; Bone scan; Positron emission tomography (PET); Prostate cancer; PSA

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 3,3 DIPHOSPHONO 1,2 PROPANE DICARBON ACID TC 99M; UNCLASSIFIED DRUG; CARBON; CHOLINE; DIAGNOSTIC AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE LESION; BONE METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER RELAPSE; CANCER STAGING; CANCER SURGERY; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG UPTAKE; HUMAN; HUMAN TISSUE; LUNG LESION; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCINTILLATION CAMERA; SENSITIVITY ANALYSIS; VALIDATION PROCESS; BLOOD; BONE; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

AGED; AGED, 80 AND OVER; BONE AND BONES; CARBON RADIOISOTOPES; CHOLINE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84864467435     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2012.04.027     Document Type: Article

References (20)

1. S.G. Roberts, M.L. Blute, E.J. Bergstralh, J.M. Slezak, and H. Zincke PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer Mayo Clinic Proceedings 76 6 2001 576 581
2. R.E. Coleman Metastatic bone disease: clinical features, pathophysiology and treatment strategies Cancer Treatment Reviews 27 2001 165 176
3. T.K. Choueiri, R. Dreicer, A. Paciorek, P.R. Carroll, and B.l. Konety A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy Journal of Urology 179 3 2008 906 910
4. O.T. Okotie, W.J. Aronson, and J.A. Wieder Predictors of metastatic diseases in men with biochemical failure following radical prostatectomy Journal of Urology 171 2004 2260 2269
5. M.L. Cher, F.J. Bianco, and J.S. Lam Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy Journal of Urology 160 1998 1387 1391
6. P. Gomez, M. Manoharan, S.S. Kim, and M.S. Soloway Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU International 94 2004 299 302
7. S.H. Zeisel Dietary choline: biochemistry, physiology and pharmacology Annual Review of Nutrition 1 1981 95 121
8. E. Sutinen, M. Nurmi, and A. Roivainer Kinetics of 11C-choline uptake in prostate cancer: a PET study European Journal of Nuclear Medicine and Molecular Imaging 31 2003 317 324
9. S.A. Muller, K. Holzapfel, C. Seidl, U. Treiber, B.J. Krause, and R. Senekowitsch-Schmidtke Characterization of choline uptake in prostate cancer cells following bicatulamide and docetaxel treatment European Journal of Nuclear Medicine and Molecular Imaging 36 2009 1434 1442
10. B.J. Krause, M. Souvatzoglou, and M. Tincel The detection rate of 11-C choline PET/TC depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer European Journal of Nuclear Medicine and Molecular Imaging 35 2008 18 23
11. M. Cimitan, R. Bortolus, and S. Morassut [18]F-fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients European Journal of Nuclear Medicine and Molecular Imaging 33 2006 1387 1398
12. C. Pascali, A. Bogni, and R. Iwata 11C-methylation on C18 SepPak cartridge: a convenient way to produce [N-methyl-11C] choline Journal of Labelled Compounds and Radiopharmaceuticals 49 2000 195 203
13. F. Saad, N. Clarke, and M. Colombel Natural history and treatment of bone complications in prostate cancer European Urology 49 March (3) 2006 429 440
14. J.M. O'Sullivan, A.R. Norman, G.J. Cook, C. Fisher, and D.P. Dearnaley Broadening the criteria for avoiding staging bone scans in prostate cancer: a retrospective study of patients at the Royal Marsden Hospital BJU International 92 2003 685 689
15. J.E. Oesterling Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications Urologic Clinics of North America 20 1993 705 711
16. L.F. Wymenga, J.H. Boomsma, K. Groenier, D.A. Piers, and H.J. Mensink Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase BJU International 88 2001 226 230
17. M. Picchio, C. Messa, and C. Landoni Value of [11C]choline positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose positron emission tomography Journal of Urology 169 2003 1337 1340
18. P. Castellucci, C. Fuccio, and C. Nanni Influence of trigger PSA and PSA kinetics on 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy Journal of Nuclear Medicine 50 2009 1394 1400
19. C. Fuccio, D. Rubello, P. Castellucci, M.C. Marzola, and S. Fanti Coline PET/CT for prostate cancer. Main clinical applications European Journal of Radiology 80 2011 e50 e56
20. M. Beheshti, R. Vali, and P. Waldenberger The use of F-18 choline PET in the assessment of bone metastases in prostate cancer: correlation with morphological changes on CT Molecular Imaging Biology 12 2010 98 107 Erratum in: Mol. Imaging Biol. 2010 Jun;12:360.